Top Banner
Implications of C. difficile diagnostic testing Not seeing the wood for the trees Warren Lowman Pathlink/ Vermaak & Partners Pathologists Wits Donald Gordon Medical Centre Clinical Microbiology & Infectious Diseases, University of the Witwatersrand
16

Implications of C. difficile diagnostic testing

Dec 31, 2015

Download

Documents

Cameron Kennedy

Implications of C. difficile diagnostic testing. Not seeing the wood for the trees Warren Lowman Pathlink / Vermaak & Partners Pathologists Wits Donald Gordon Medical Centre Clinical Microbiology & Infectious Diseases, University of the Witwatersrand. Pubmed & C. difficile. 9298 hits - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Implications of  C. difficile  diagnostic testing

Implications of C. difficile diagnostic testing

Not seeing the wood for the trees

Warren LowmanPathlink/ Vermaak & Partners Pathologists

Wits Donald Gordon Medical CentreClinical Microbiology & Infectious Diseases, University of the

Witwatersrand

Page 2: Implications of  C. difficile  diagnostic testing

Pubmed & C. difficile

1. 9298 hits2. + Clinical trials = 3303. + Diagnosis = 1694. + Testing = 20

Page 3: Implications of  C. difficile  diagnostic testing

Clinical relevance…

2 key issues that are largely ignored:–Pre-test probability–PPV

Page 4: Implications of  C. difficile  diagnostic testing

ICU HC Surgical Medical Oncology0

20

40

60

80

100

120

C. diff pos+C. diff requestsN

o.

Are we selecting accurately?

67.1 tests/ 10 000 pt bed days (range, 29 – 153)

Page 5: Implications of  C. difficile  diagnostic testing

C. difficile diagnostics…

1. We are floundering- survey of UK labs indicate >25 different algorithms

2. Multitude of different assays3. Impacts on our understanding of the

epidemiology of CDI.

Jan Feb Mar AprMay Jun Jul AugSeptOct Nov Dec0

2

4

6

8

10

12

C. diff Rate/ 10 000 patient days

Rate (/10 000 pt days)2013 Cumulative rate

Page 6: Implications of  C. difficile  diagnostic testing

The “best” study

Lancet Infect Dis 2013

1.Diagnostic assays2.Study design3.Clinical data

Page 7: Implications of  C. difficile  diagnostic testing

Salient points

1. Tested all faecal samples irrespective of request

2. Wide scope of practice3. Detection of 3 targets: bacterium; toxin; gene4. Predefined groups: diagnostic; severity5. Statistically very “sound”6. Diagnostic performance assessed in training

phase

Page 8: Implications of  C. difficile  diagnostic testing

Clinical relevance by assay

1. Data for 6522 inpatient episodes

Variable Grp1 vs Grp2 Grp1 vs Grp3

Mean WCC 0.0004 <0.0001

Died 0.022 <0.0001

Death rate 0.0195 0.0033

Page 9: Implications of  C. difficile  diagnostic testing

…clinical relevance by assay1. Same comparison using PCR as surrogate for

cytotoxigenic culture

Variable Grp1 vs Grp2 Grp1 vs Grp3

Mean WCC <0.0001 <0.0001

Died 0.004 <0.0001

Death rate 0.0317 0.0018

Page 10: Implications of  C. difficile  diagnostic testing

The point…clinically

Page 11: Implications of  C. difficile  diagnostic testing

So what do we do about diagnosis?

Page 12: Implications of  C. difficile  diagnostic testing

What’s best?

Performance GDH + EIA NAAT + EIA

Sensitivity 81.8% 82.9%

Specificity 99.5% 99.6%

PPV 91.6% 92.1%

NPV 98.9% 98.9%

Page 13: Implications of  C. difficile  diagnostic testing

The implications

TOXIN POSITIVITY

DIAGNOSTIC ASSAY

CLINICAL OUTCOME

MANAGEMENT

Page 14: Implications of  C. difficile  diagnostic testing

C. difficile excretors…an issue?

Overtreatment…excessive antibiotic use!Cost…this all adds up

GDH EIA Toxin PCR

POSITIVE 14 7 14

NEGATIVE 11 18 11

Page 15: Implications of  C. difficile  diagnostic testing

3-stage algorithmGDH

EIA Toxin

Not CDAD

CDAD

NAAT

C. difficile excretor

Not CDAD8%

Page 16: Implications of  C. difficile  diagnostic testing

Thank you!